Skip to main content
. 2018 Nov 28;120(2):256–268. doi: 10.1038/s41416-018-0273-9

Fig. 1.

Fig. 1

PRISMA flow diagram of identification and selection of eligible studies. *Included in discussion with respect to estimation of absolute risk of subsequent HPV-associated cancer, Table S1. #Included in Table S2